Picture of Gabather AB logo

GABA — Gabather AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Gabather Completes Toxicological Studies

July 3 (Reuters) - GABATHER AB  GABAT.ST :
    * GABATHER HAS COMPLETED TOXICOLOGICAL STUDIES
    * COMPOUND WAS GENERALLY SAFE AND WELL TOLERATED IN REPEATED
DOSE
ADMINISTRATIONS FOR 28 DAYS IN ANIMALS
    * SAYS SAFETY PHARMACOLOGY WAS WITHOUT ANY REMARKS, AND
GT-002
SHOWED NO NEGATIVE CARDIOVASCULAR TREATMENT-RELATED EFFECTS

Source text for Eikon:  ID:nWkrbJg33j 
Further company coverage:  GABAT.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Gabather AB

See all news